Sign in Subscribe
Cancer

Breakthroughs in Personalized Medicine: A New Era for Precision Therapy

Strategic Insights

— 1 min read

Researchers at Tel Aviv University have made a significant contribution to the field of personalized medicine, highlighting the impact of technological advancements on modern medicine. According to the study, the Human Genome Project has paved the way for a new age in medicine, enabling a deeper understanding of biological processes at various levels of analysis. The focus of the research is on the insulin-like growth factor-1 (IGF1) axis, which plays a crucial role in physiological and pathological conditions. The study aims to provide an overview of the IGF system, emphasizing ongoing efforts to target the IGF axis for therapeutic purposes.

Key Takeaways:

  • The Human Genome Project has been instrumental in the development of precision medicine, enabling a deeper understanding of biological processes.
  • The IGF1 axis is an essential endocrine network with key roles in physiological and pathological conditions.
  • Researchers at Tel Aviv University are exploring the potential of the IGF axis for therapeutic purposes, with a focus on cancer therapy.
  • Precision medicine has the potential to revolutionize clinical research and improve patient outcomes.
  • The study highlights the importance of understanding the IGF system, particularly in the context of cancer therapy and personalized medicine.
  • Ilan Bruchim and Haim Werner were involved in the research, along with other authors from the Department of Human Molecular Genetics and Biochemistry at Tel Aviv University.
  • The research was published in the journal Exploration of Medicine, 2025, 6(), 1001342, and is available online at https://doi.org/10.37349/emed.2025.1001342.

Statistics:

  • 25 years of technological breakthroughs have had a significant impact on modern medicine.
  • The Human Genome Project has enabled a new age in medicine, commonly referred to as Precision or Personalized Medicine.
  • The IGF1 axis plays a key role in both physiological conditions, such as growth and development, and pathological conditions, including cancer and metabolic disorders.
  • The research aims to provide an overview of the IGF system, with a particular emphasis on ongoing efforts to target the IGF axis for therapeutic purposes.
  • The potential impact of precision medicine on IGF1 clinical research is discussed, highlighting the importance of understanding the IGF system in the context of cancer therapy and personalized medicine.

Sources:

  • NewsRx. Research from Tel Aviv University Yields New Data on Personalized Medicine (Precision medicine, insulin-like growth factors and cancer therapy). Health & Medicine Week. July 25, 2025; p 3756.
  • "Precision medicine, insulin-like growth factors and cancer therapy. Exploration of Medicine, 2025,6():1001342. doi: 10.37349/emed.2025.1001342"

Read more